Lower Cholesterol:
Lower Cholesterol, High Cholesterol, Reduce Cholesterol, Articles on Cholesterol Management
-
Feb 20th, 2009
While some experts have recently recommended more aggressive cholesterol screening in childhood, less than 1 percent of adolescents 12–17- years-old may potentially qualify for cholesterol-lowering drugs.
-
Feb 16th, 2009
Americans continue to become more obese, but cholesterol profiles significantly show improvement. Specifically, good (HDL) levels have increased, and triglyceride levels are lower, despite obesity in America.
-
Jan 14th, 2009
Researchers estimate more than 11 million older Americans may be newly eligible for statin therapy if findings from a recently published large clinical trial are adopted into clinical practice guidelines.
-
Jan 13th, 2009
Seventy-five percent of heart attacks occur in people whose cholesterol levels fall within current national guidelines established to prevent heart attack. The findings, published in the January issue of the American Heart Journal, suggest that current national guidelines for LDL (bad cholesterol) levels less than 100mg/dL for those at risk for heart attack, and less than 130mg/dL for the general population, should be scrutinized more closely.
-
Jan 10th, 2009
Researchers at Northwestern University have developed a synthetic form of HDL (the good) cholesterol to help us fight heart disease. "We have designed and built a cholesterol sponge. The synthetic HDL features the basics of what a great cholesterol drug should be."
-
Dec 17th, 2008
Scientists have identified genetic mutations that may help explain why some people don't respond very well to statins, drugs taken by millions of Americans to fight high cholesterol and prevent coronary artery disease.
-
Dec 16th, 2008
New cholesterol management therapy with Trilplix in combination with a Statin helped patients improve HDL and LDL cholesterol and triglycerides in clinical studies, thus leading to FDA approval of Abbott's drug.
-
Nov 12th, 2008
Using the VAP Cholesterol Test from Atherotech investigators have reported beneficial changes in lipoprotein subclasses and LDL particle size using combination therapy.
-
Nov 12th, 2008
Use of the cholesterol medication Crestor to prevent cardiovascular events in patients who do not have high cholesterol levels but have high levels of C-reactive protein would increase U.S. health care costs by $10 billion annually.
-
Nov 10th, 2008
Major new media outlets have become very exited over Crestor, which is a cholesterol-lowering drug produced by AstraZeneca and is within a classification of drugs called “Statins”. The manufacturer began a four-year study called “Jupiter” and ended it after two years claiming astounding results:
